Skip to main content

Syndax Pharmaceuticals Inc

SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001395937

In the last 90 days, Syndax Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 242 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.

Superinvestors holding SNDX, Q2 2026

See all superinvestors

No superinvestor reported holding SNDX in Q2 2026.